Volker Viereck - Gynecology

Author Information

Volker Viereck is a distinguished researcher affiliated with the Department of Gynecology and Obstetrics at Cantonal Hospital Frauenfeld, located in 8501 Frauenfeld, Switzerland. His work primarily focuses on gynecological and urological disorders, with a significant emphasis on urinary incontinence and bladder-related conditions.

Research Contributions

Volker Viereck has made substantial contributions to the field of gynecology and urology. His research covers various aspects of urinary incontinence, including innovative treatments such as combination therapy with botulinum toxin and bulking agents for elderly women with mixed urinary incontinence. He has also explored the efficacy of Erbium:YAG laser treatment for female stress urinary incontinence and examined the role of mast cells as biomarkers for bladder pain syndrome/interstitial cystitis. His work is widely recognized and cited in the medical community, reflecting his profound impact on his field of expertise.

Aliases

Volker Viereck is also known by several aliases including V Viereck and V. Viereck.

Publication and Citation Metrics

Metric	Value
Citation Count	3174
H-Index	33
Paper Count	95

Publications:

Combination therapy with botulinum toxin and bulking agent—An efficient, sustainable, and safe method to treat elderly women with mixed urinary incontinence

DOI: 10.1002/nau.24757

Year: 2021

Urinary Incontinence

DOI: 10.1007/978-3-030-43985-9_23

Year: 2020

Erbium:YAG laser treatment of female stress urinary incontinence: midterm data

DOI: 10.1007/s00192-019-04148-9

Year: 2019

[Acute and recurrent urinary tract infections in women presenting in primary practice].

DOI: 10.1024/0040-5930/a001042

Year: 2019

Re: Kirchin V, Page T, Keegan PE, Atiemo KO, Cody JD, McClinton S, Aluko P. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2017 Jul 25;7:CD003881. doi: 10.1002/14651858.CD003881.pub4.

DOI: 10.1002/nau.23712

Year: 2018

Mast Cells as Biomarkers for Bladder Pain Syndrome/Interstitial Cystitis?

DOI: 10.1007/978-3-319-61449-6_10

Year: 2018

Have we been led astray by the NGF biomarker data?

DOI: 10.1002/nau.22882

Year: 2017

Current Treatment Concepts for Stress Urinary Incontinence.

DOI: 10.1024/1661-8157/a002843

Year: 2017

Urethral bulking for recurrent stress urinary incontinence after midurethral sling failure

DOI: 10.1002/nau.23007

Year: 2017

Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome

DOI: 10.1016/j.juro.2016.06.089

Year: 2017

How is Melasma Treated?

What Conditions Are Exacerbated by Heavy Lifting?

What is the Certifying Examination in Gynecology?

Why is Dosage Verification Important?

What Should Women with Chronic Health Conditions Do?

How do kidney disorders affect menstrual cycles?

Who Can Use Copper IUDs?

Can These Practices Aid in Pain Management?

How is Lung Volume Measured?

How do Hormonal Contraceptives Benefit Women's Health?

Partnered Content Networks

Relevant Topics